Stock Analiz

Lexicon Pharmaceuticals, Inc. (LXRX) stock forecast and price target

Price $1.79 · data as of November 13, 2026

12-month price target

Average target$4.51
Upside / downside+152.2%
Analysts6
ConsensusBuy
Low $1.69Average $4.51High $8.00

Gold marker: average target · white marker: today’s price ($1.79)

Analyst ratings

Strong buy 1Buy 3Hold 2Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.16−13.5%$37M
Next fiscal year
ends December 31, 2027
$-0.21−34.0%$18M
Next quarter
ends December 31, 2026
$-0.05−35.5%$4M
Quarter after
ends March 31, 2027
$-0.06+0.0%$603330

Consensus of the analysts covering Lexicon Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Lexicon Pharmaceuticals stock price target?

The average 12-month target from 6 analysts is $4.51, 152.2% above the current price of $1.79 Targets range from $1.69 to $8.00.

Is Lexicon Pharmaceuticals a buy according to analysts?

The consensus rating is “Buy” (1 strong buy, 3 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Lexicon Pharmaceuticals expected to earn?

Analysts expect EPS of $-0.16 for the fiscal year ending December 31, 2026 and $-0.21 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.